Elucidation of Proteoforms of Chinese Hamster Ovary (CHO) Phospholipase B‐Like 2 (PLBL2) Captured From a Monoclonal Antibody
Open Access
- 10 November 2025
- journal article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (2) , 406-419
Abstract
Removing host cell proteins (HCPs) during biotherapeutic manufacturing is essential to ensure patient safety and supply continuity. Yet, this goal remains exceptionally challenging for some HCP species. For example, phospholipase B‐like‐2 (PLBL2) from Chinese hamster ovary (CHO) cells plagues process engineers by evading typical purification strategies. Separation challenges for CHO PLBL2 and other HCPs are due in large part to a dearth of detailed biochemical characterization for HCPs, such as their proteoforms or variants. Herein, we present as a case study the elucidation of proteoforms of PLBL2, which was endogenously expressed in CHO alongside pembrolizumab (a monoclonal IgG4 antibody) and inadvertently co‐purified following a typical downstream process. Using site‐specifically modified polyclonal anti‐CHO PLBL2 antibodies immobilized onto a solid support, CHO PLBL2 was captured from pembrolizumab, enriched, and recovered, enabling deep characterization by mass spectrometry and other techniques. These analyses revealed a detailed understanding of CHO PLBL2's proteoforms, including charge variants, N‐linked and O‐linked glycosylation, phosphorylation, and cleavage to afford multiple molecular weight isoforms. To the best of our knowledge, this is the first published, deep characterization of a challenging CHO HCP. Armed with a greater understanding of the impurities that plague purification processes, we can design new, targeted strategies to ensure their removal and safeguard both patient safety and biotherapeutic supplies. While our work centered on CHO PLBL2, our antibody immobilization, affinity enrichment, and characterization approach should be broadly applicable to enable the examination of innumerable challenging HCPs from modalities across the increasingly diverse bioprocessing landscape.Keywords
This publication has 49 references indexed in Scilit:
- Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell linesBiotechnology and Bioengineering, 2022
- Towards continuous mAb purification: Clearance of host cell proteins from CHO cell culture harvests via “flow‐through affinity chromatography” using peptide‐based adsorbentsBiotechnology and Bioengineering, 2022
- Targeted capture of Chinese hamster ovary host cell proteins: Peptide ligand binding by proteomic analysisBiotechnology and Bioengineering, 2019
- Implementation of an experimental and computational tool set to study protein‐mAb interactionsBiotechnology Progress, 2019
- Investigation of cathepsin D–mAb interactions using a combined experimental and computational tool setBiotechnology and Bioengineering, 2019
- Knockout of a difficult‐to‐remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulationsBiotechnology and Bioengineering, 2016
- Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody productBiotechnology Progress, 2015
- Identification and characterization of host cell protein product‐associated impurities in monoclonal antibody bioprocessingBiotechnology and Bioengineering, 2013
- Degradation of an Fc‐fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D proteaseBiotechnology and Bioengineering, 2009
- Host cell proteins in biologics development: Identification, quantitation and risk assessmentBiotechnology and Bioengineering, 2009